UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome ...

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your ...

Hovde Group：维持United Community Banks(UCB.US)评级，由大市一致调整至大市一致评级, 目标价由36.00美元调整至32.00美元。 美国社区银行（UCB.US）公司简介 ...

The demand for expertise in Physics and Astronomy has surged as breakthroughs in quantum mechanics and space exploration ...

UCB, a global biopharmaceutical company, today announced it will present 8 scientific abstracts, including 3 late-breaker oral presentations, highlighting key data from its innovative ...

The new drug joins UCB’s recently FDA-approved FcRn-targeting antibody Rystiggo (rozanolixizumab), which got the nod from the US regulator in June for gMG patients who are either AChR or anti ...

Investors might want to bet on United Community Banks (UCB), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

and speculated that UCB may opt to partner the drug. For now though, the drugmaker is going it alone. Bimekizumab has also been filed for approval in the US, where a decision is due by 15 October ...

UCB will offer bespoke financial services tailored to support their transition to self-employment. The Raise Project, operated by WEWB, is dedicated to fostering job creation and promoting ...